Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
SHEA Updates Guidance for Health Care Staff With Hepatitis, HIV
Career counseling recommended for those planning to conduct exposure-prone procedures
Findings Conflicted for Benefit of Tocilizumab in COVID-19
One trial shows reduction in mortality, but no evidence of efficacy seen in two additional trials
Survival From COVID-19 High in Patients With Psoriasis
Risk for hospitalization increased for patients using nonbiologic systemic therapy versus biologics
Convalescent Plasma Has Limited Benefit for Moderate COVID-19
Randomized phase II trial shows no drop in progression to severe disease, all-cause deaths
Skin Breaks Drop With Prolonged AL/CVL Use in Neonates
Larger thalamic volumes seen with prolonged arterial line, central venous line use and fewer skin breaks
Cytokines Not at ‘Storm’ Levels in Those With Severe COVID-19
Levels in severely, critically ill COVID-19 patients much lower than in other inflammatory syndromes
Algorithm Predicts Death, Hospital Admission From COVID-19
Final risk algorithm includes age, ethnicity, deprivation, body mass index, range of comorbidities
Tocilizumab Does Not Prevent Intubation, Death in COVID-19
Intubation or death, disease worsening similar for tocilizumab, placebo in hospitalized patients
CDC: Number of COVID-19 Deaths May Be Underreported
Only two-thirds of the nearly 300,000 excess deaths in 2020 are attributed to COVID-19
